Stockscreener 앱 받기
4.39
5.59%
-0.26
시간 외 거래:
4.77
0.38
+8.66%
Evoke Pharma Inc 주식(EVOK)의 최신 뉴스
Evoke Pharma Inc. Stock Analysis and ForecastMassive wealth growth - jammulinksnews.com
What analysts say about Evoke Pharma Inc. stockTriple-digit profit margins - jammulinksnews.com
Is Evoke Pharma Inc. a good long term investmentRapid wealth creation - jammulinksnews.com
What drives Evoke Pharma Inc. stock priceFree Risk Assessment Services - jammulinksnews.com
What drives bioAffinity Technologies Inc. Equity Warrant stock priceRemarkable growth - Autocar Professional
What analysts say about PSQH stockFree Stock Market Forecast Reports - Jammu Links News
MGP Ingredients Inc. Stock Analysis and ForecastTriple-digit returns - jammulinksnews.com
Evoke Pharma Shares Jump 50% Following Patent Approval for GIMOTI - MSN
Why did EVOK's Q4 2024 earnings beat forecasts? - AInvest
How Evoke Pharma Inc. stock performs during market volatilityReal Time Breakout Tracking - Newser
Why Evoke Pharma Inc. stock attracts strong analyst attentionStrong Buy Recommendations - Newser
What makes Evoke Pharma Inc. stock price move sharplyVerified Chart Patterns - Newser
Small Cap Stocks Worth Watching – July 9th - Defense World
Promising Pharmaceutical Stocks To Watch Now – July 9th - Defense World
Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile In - NewsBreak: Local News & Alerts
Evoke Pharma skyrockets on patent allowance for diabetes nasal spray drug - Mugglehead Magazine
Evoke Pharma receives patent allowance for gastroparesis nasal spray By Investing.com - Investing.com South Africa
Evoke Pharma (EVOK) Soars 162.78% on Patent Extension - AInvest
Crude Oil Moves Higher; RxSight Shares Plunge - Benzinga
Evoke Pharma shares surge 24.57% intraday after receiving Notice of Allowance for U.S. patent application for GIMOTI®. - AInvest
Evoke Pharma (EVOK) Shares Skyrocket On New Patent: What's Going On? - Benzinga
Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May - Benzinga
Evoke Pharma Shares Soar After Patent Allowance for Gastroparesis Treatment - MarketScreener
Evoke Pharma (EVOK) Stock Soars Following Positive Patent News - Stocks Telegraph
Evoke Pharma: Is the Bounce Back Real? - StocksToTrade
EVOK Stock: Boom or Bust? - timothysykes.com
Evoke Pharma (EVOK) Secures New Patent Approval for GIMOTI | EVO - GuruFocus
Evoke Pharma stock soars after receiving patent allowance for GIMOTI By Investing.com - Investing.com South Africa
Evoke Pharma stock soars after receiving patent allowance for GIMOTI - Investing.com
1.09%
0.96%
자본화:
|
볼륨(24시간):